发布于: 公告转发:0回复:0喜欢:0
$RXi Pharmaceuticals (RXII)$ 8-K - Current report Filed: 2016-04-15 AccNo: 0001193125-16-542971 Size: 47 KBItem 3.03: Material Modifications to Rights of Security HoldersItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 5.07: Submission of Matters to a Vote of Securi 网页链接